Biotechnology News

View:

  • GMO corn: France rejects report by EU food agency

    AFP – Fri Jul 3, 1:48 pm ET

    PARIS (AFP) - France on Friday rejected a report by the European Union's food safety watchdog that said a controversial strain of genetically-modified corn was safe.

  • Tamiflu-resistant swine flu patient found in Japan: govt

    AFP – Thu Jul 2, 5:19 pm ET

    TOKYO (AFP) - A genetic mutation of swine flu that is resistant to the anti-viral Tamiflu has been discovered in Japan, the first such case in the country, the health ministry said.

  • Study: New flu inefficient in attacking people

    AP – Thu Jul 2, 5:03 pm ET

    WASHINGTON - With swine flu continuing to spread around the world, researchers say they have found the reason it is — so far — more a series of local blazes than a wide-raging wildfire. The new virus, H1N1, has a protein on its surface that is not very efficient at binding with receptors in people's respiratory tracts, researchers at the Harvard-MIT Division of Health Sciences and Technology report in Friday's edition of the journal Science.

  • Master Stem Cell for Human Heart Identified

    HealthDay – Wed Jul 1, 11:49 pm ET

    WEDNESDAY, July 1 (HealthDay News) -- For the first time, researchers have identified a single "master" stem cell in humans that is capable of differentiating into all three major cell types that make up the human heart.

  • Ill. cancer researcher wins $500K genetics prize

    AP – Wed Jul 1, 10:17 am ET

    CHICAGO - An 84-year-old University of Chicago researcher has won a half-million-dollar genetics prize for her pioneering work in showing that cancer is a genetic disease.

  • Biogen Buys Rights to Acorda’s MS Pill Outside U.S.

    Bloomberg – Wed Jul 1, 9:39 am ET

    July 1 (Bloomberg) -- Biogen Idec Inc., the world’s largest maker of drugs for multiple sclerosis, will pay as much as $510 million for rights to market Acorda Therapeutics Inc.’s experimental MS pill outside the U.S.

  • GE teams up with Geron for stem-cell research

    Reuters – Tue Jun 30, 4:36 pm ET

    BOSTON (Reuters) - General Electric Co is teaming up with U.S. biotech company Geron Corp to use stem cells to develop products that could give drug developers an early warning of whether new medicines are toxic.

  • GMO maize strain safe: EU food agency

    AFP – Tue Jun 30, 11:41 am ET

    BRUSSELS (AFP) - A genetically modified strain of maize, banned in some EU countries, poses no risk to health or the environment, the European Food Safety Authority declared on Tuesday.

  • Biogen reports 10th case of PML brain infection

    Reuters – Mon Jun 29, 12:23 pm ET

    BOSTON (Reuters) - A 10th patient taking Biogen Idec Inc's Tysabri has developed a potentially deadly brain infection since the multiple sclerosis drug was reintroduced to the market in July 2006, sending the company's shares down nearly 7 percent.

  • Genetically Modified Rice Fights Allergies

    LiveScience.com – Sat Jun 27, 4:50 pm ET

    What if the food we ate fought allergies instead of causing them? A new form of rice can, researchers announced this week. But is it safe?

Pagination